Very cheap and cost saving therapy instead of $100,000 a patient treatments. This should be a no brainer for the FDA-and EMA we could probably produce this treatment for half the cost and be the SOC for various cancers! With the cost of treatments going through the roof ADXS could be a life saving alternative to countries that cannot afford pricy treatments that exist in the U.S .